OWIM
TBPH icon

Old West Investment Management’s Theravance Biopharma TBPH Stock Holding History

Old West Investment Management’s Portfolio TBPH Stock Details TBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-17,592
Closed -$359K – 71
2021
Q1 		$359K Hold
17,592
– – 0.08% 50
2020
Q4 		$312K Buy
17,592
+7,504
+74% +$135K 0.07% 49
2020
Q3 		$149K Sell
10,088
-78
-0.8% -$1.46K 0.03% 53
2020
Q2 		$213K Sell
10,166
-92
-0.9% -$2.36K 0.06% 50
2020
Q1 		$237K Sell
10,258
-926
-8% -$23.2K 0.18% 49
2019
Q4 		$289K Hold
11,184
– – 0.11% 61
2019
Q3 		$217K Sell
11,184
-1,758
-14% -$35.5K 0.13% 58
2019
Q2 		$211K Sell
12,942
-86,924
-87% -$1.76M 0.1% 61
2019
Q1 		$2.26M Sell
99,866
-10,312
-9% -$261K 0.82% 31
2018
Q4 		$2.82M Sell
110,178
-1,083
-1% -$29.2K 0.76% 24
2018
Q3 		$3.63M Buy
111,261
+160
+0.1% +$4.36K 1.5% 23
2018
Q2 		$2.52M Buy
111,101
+1,781
+2% +$42.3K 1.27% 28
2018
Q1 		$2.65M Sell
109,320
-4,542
-4% -$125K 1.53% 24
2017
Q4 		$3.17M Sell
113,862
-80
-0.1% -$2.37K 1.81% 22
2017
Q3 		$3.9M Sell
113,942
-6,835
-6% -$224K 2.05% 21
2017
Q2 		$4.81M Sell
120,777
-20,397
-14% -$784K 2.57% 15
2017
Q1 		$5.2M Buy
141,174
+89,158
+171% +$2.85M 2.76% 13
2016
Q4 		$1.66M Buy
52,016
+6,362
+14% +$197K 1.01% 23
2016
Q3 		$1.65M Buy
45,654
+2,573
+6% +$71.6K 1.2% 24
2016
Q2 		$977K Buy
43,081
+4,193
+11% +$90.5K 0.71% 29
2016
Q1 		$731K Sell
38,888
-4,479
-10% -$73.3K 0.61% 36
2015
Q4 		$710K Sell
43,367
-12,759
-23% -$202K 0.64% 40
2015
Q3 		$616K Buy
56,126
+19,997
+55% +$255K 0.47% 46
2015
Q2 		$470K Buy
36,129
+16,512
+84% +$256K 0.33% 60
2015
Q1 		$340K Sell
19,617
-194
-1% -$3.56K 0.23% 71
2014
Q4 		$295K Buy
19,811
+8,850
+81% +$154K 0.18% 76
2014
Q3 		$252K Buy
+10,961
New +$318K 0.16% 78

Other funds holding TBPH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MS
Maven Securities St Helier, Jersey $5.2B AUM 44.01% 1-Year Est. Return
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Old West Investment Management's TBPH Position: Q2 2021 in Review

Old West Investment Management sold out of Theravance Biopharma (TBPH) in Q2 2021, closing a stake of 17,592 shares — an estimated $359K sold.

Old West Investment Management first reported a position in TBPH in Q3 2014 and held it in 27 quarters. The position peaked at $5.2M in Q1 2017. 108 funds tracked by Wall St. Rank hold TBPH as of Q2 2021.

  • Old West Investment Management reported no remaining Theravance Biopharma position as of Q2 2021 after selling out during the quarter.
  • Old West Investment Management sold 17,592 Theravance Biopharma shares in Q2 2021, an estimated $359K.
  • Old West Investment Management first reported a position in Theravance Biopharma in Q3 2014 and held it in 27 quarters.
  • Old West Investment Management's Theravance Biopharma position peaked at $5.2M in Q1 2017.
  • 108 funds tracked by Wall St. Rank held Theravance Biopharma as of Q2 2021.

Based on Old West Investment Management's 13F filing for Q2 2021, filed 12 Aug 2021.